A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Pfizer Plans to Release COVID-19 Pill by the End of 2021


Pfizer CEO Albert Bourla, DVM, PhD, announced on April 27 that the company hopes to release an at-home, oral drug designed to inhibit the enzymes that SARS-CoV-2 requires to reproduce in human cells. Pfizer began testing of the antiviral medication in early March. The company is simultaneously working on an injectable antiviral medication also. Combined with COVID-19 immunizations, a treatment that can mitigate COVID-19 illness immediately while being administered at home could be a game changer in the fight against the novel coronavirus. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy